LSPedia, a global leader in pharmaceutical traceability and supply chain SaaS solutions, has secured its second major U.S. government contract, the MMCAP Infuse DSCSA Compliance contract. This follows its national DSCSA contract with the U.S. Department of Veterans Affairs, further solidifying LSPedia's leadership position in the US pharmaceutical supply chain.

 MMCAP Infuse member facilities will also be able to implement LSPedia's advanced Recall Management and Expiration Management systems relevant to in-stock inventory. This intelligent recall management system eliminates noise from irrelevant notifications, brings focus to staff, and ensures full compliance with regulatory requirements.

Additionally, LSPedia's Investigator™ is the industry's only fully automated, collaborative Exceptions Management platform, resolving EPCIS, VRS, and logistics exceptions in near real-time across the pharmaceutical supply chain. By eliminating manual exception handling, Investigator streamlines compliance, prevents supply chain disruptions, and ensures data accuracy between trading partners.

"Hospitals and healthcare facilities need more than just DSCSA compliance; they need a solution that enhances efficiency and strengthens their bottom line," said Daniel MacKinnon, SVP of Sales and Marketing at LSPedia. "With this contract, MMCAP Infuse members gain access to the best-in-class tools to streamline operations, reduce administrative burdens, and focus on what matters most—delivering exceptional patient care."